ArticleScientific reports2022

Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study.

Zijing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.